Early clinical trials with colony-stimulating factors.
Morstyn
G
G
Ludwig Institute for Cancer Research, P.O. Royal Melbourne Hospital, Victoria, Australia.
Lieschke
G J
GJ
Cebon
J
J
Dührsen
U
U
Villeval
J L
JL
Sheridan
W
W
McGrath
K
K
Layton
J E
JE
D002986:Clinical Trials as Topic; D003115:Colony-Stimulating Factors / Q000627:therapeutic use*; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006133:Growth Substances / Q000627:therapeutic use*; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D009503:Neutropenia / Q000517:prevention & control; D011994:Recombinant Proteins / Q000627:therapeutic use
D003115:Colony-Stimulating Factors; D006133:Growth Substances; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor